SavedAdd your journal

Journals / Erciyes Medical Journal / 2019 / Cilt: 41 - Sayı: 3

The Effect of Carbapenem Restriction Policy on the Rate of Hospital Infections Due To Resistant Microorganisms in the Intensive Care Unit

Zeynep TÜRE
Gökşen ÖZ
Tuğba DEMİREL GÜĞÜL
ŞERİFE ÇETİN
Tuğba BULUT
Saliha AYDIN
İLHAMİ ÇELİK
Pages
333–336
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Carbapenem restriction policy may contribute to decrease the rate of resistant bacterial infections.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This study aims to investigate the effect of carbapenem restriction on the infection rate and antibiotic susceptibility.
📊
Key Findings & Data:We compared the usage rate of antipseudomonal carbapenem, the incidence of nosocomial infection, invasive device days, the causative microorganisms, and antibiotic susceptibility.
💡
Conclusion & Impact:Carbapenem restriction policy may contribute to decrease the rate of resistant bacterial infections.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

This study aims to investigate the effect of carbapenem restriction on the infection rate and antibiotic susceptibility. We divided the study period into two: carbapenem-free period (CFP) and carbapenem-restricted period (CRP). We compared the usage rate of antipseudomonal carbapenem, the incidence of nosocomial infection, invasive device days, the causative microorganisms, and antibiotic susceptibility. The nosocomial infection density was 40.95±19.02 in 1000 patient days in the CFP, and 20.71±4.28 in 1000 patient days in the CRP. We observed no significant difference between the two periods in terms of invasive devices use rates. Anti pseudomonal carbapenem usage rate was 2.73 in CFP and 1.67 in CRP. Of the 40 nosocomial infections due to Acinetobacter baumannii, 27 of them were found in the CFP. Carbapenem restriction policy may contribute to decrease the rate of resistant bacterial infections.

🔖

Cite This Article

TÜRE, Z., ÖZ, G., GÜĞÜL, T. D., ÇETİN, Ş., BULUT, T., AYDIN, S., ÇELİK, İ. (2019). The Effect of Carbapenem Restriction Policy on the Rate of Hospital Infections Due To Resistant Microorganisms in the Intensive Care Unit. Erciyes Medical Journal, Cilt: 41 - Sayı: 3, 333–336. https://ajindex.com/articles/173339

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Jarrell AS, Kruer RM, Berescu LD, Pronovost PJ, Trivedi JB. Factors associated with in-hospital mortality among critically ill surgical patients with multidrug-resistant Gram-negative infections. J Crit Care 2018; 43: 321–6. [CrossRef] Soltani J, Pouladfar G, Versporten A, Sharland M, Goossens H, Jafarpour Z, et al. Point Prevalence Survey of Antimicrobial Prescription and Infection in Pediatric and Neonatal Wards of Two Iranian Teaching Hospitals. Erciyes Med J 2019; 41(1): 25–32.
  2. Tran TB, Velkov T, Nation RL, Forrest A, Tsuji BT, Bergen PJ, et al. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet? Int J Antimicrob Agents 2016; 48(6): 592–7. [CrossRef] Rashizal Sazli MR, Syed Mohamed AF, Wan Mazuan WM, Ling SM, Mahmud A, Amin Nordin S. Colistin-associated nephrotoxicity among patients in intensive care units (ICU) of hospitals in Selangor. Med J Malaysia 2017; 72(2): 100–5. Theuretzbacher U. Recent FDA Antibiotic Approvals: Good News and Bad News. CDDEP 2015 March (cited 2017 Dec. 12) Available from: URL: https://www.cddep.org/blog/posts/recent_fda_antibiotic_approvals_good_news_and_bad_news/.
  3. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infectionand criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36(5): 309–32. [CrossRef] Taghizadeh-Ghehi M, Ahmadvand A, Chaibakhsh S. Comment on ‘Clinical impact of non-antibiotic recommendations by a multi-disciplinary antimicrobial stewardship team’. Int J Antimicrob Agents 2018;51(2): 276–7. [CrossRef] Norwegian Instute of Public Health.Updates included in the ATC/DDD Index. WHOCC 2018 Nov (cited 2017 Dec.22) Available from: URL: https://www.whocc.no/atc_ddd_index/?code=J01MA02.
  4. Ogutlu A, Guclu E, Karabay O, Utku AC, Tuna N, Yahyaoglu M. Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients. Ann Clin Microbiol Antimicrob 2014; 13: 7. [CrossRef] Altunsoy A, Aypak C, Azap A, Ergönül Ö, Balık İ. The impact of a nation wide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey. Int J Med Sci 2011; 8(4): 339–44. [CrossRef] Wu CT, Chen CL, Lee HY, Chang CJ, Liu PY, Li CY, et al. Decreased antimicrobial resistance and defined daily doses after implementation of a clinical culture-guided antimicrobial stewardship program in a local hospital. J Microbiol Immunol Infect 2017; 50(6): 846–56. [CrossRef] F